Latest market price
50.39
-0.18-0.36%
TVTXQT61Travere Therapeutics, Inc.·NASDAQ
50.39-0.36%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 19, 20264Statement of changes in beneficial ownership
Sep 21, 20268-KCurrent report
Sep 17, 20264Statement of changes in beneficial ownership
Sep 17, 20264Statement of changes in beneficial ownership
Sep 17, 20264Statement of changes in beneficial ownership
Sep 17, 20264Statement of changes in beneficial ownership
Sep 17, 20264Statement of changes in beneficial ownership
Sep 17, 20264Statement of changes in beneficial ownership
Sep 17, 20264Statement of changes in beneficial ownership
Sep 11, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 2026SC 13GBeneficial ownership statement (passive)
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 04, 20268-KCurrent report
Aug 04, 202610-QQuarterly report
Jul 09, 20268-KCurrent report
Jun 22, 20264Statement of changes in beneficial ownership
Jun 17, 2026S-8Registration of employee benefit securities
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20268-KCurrent report
Jun 16, 20264Statement of changes in beneficial ownership
Jun 02, 20268-KCurrent report